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Abstract
Background: While much progress has been made in understanding stem cell (SC) function, a complete description of the
molecular mechanisms regulating SCs is not yet established. This lack of knowledge is a major barrier holding back the
discovery of therapeutic uses of SCs. We investigated the value of a novel meta-analysis of microarray gene expression in
mouse SCs to aid the elucidation of regulatory mechanisms common to SCs and particular SC types.
Methodology/Principal Findings: We added value to previously published microarray gene expression data by
characterizing the promoter type likely to regulate transcription. Promoters of up-regulated genes in SCs were characterized
in terms of alternative promoter (AP) usage and CpG-richness, with the aim of correlating features known to affect
transcriptional control with SC function. We found that SCs have a higher proportion of up-regulated genes using CpG-rich
promoters compared with the negative controls. Comparing subsets of SC type with the controls a slightly different story
unfolds. The differences between the proliferating adult SCs and the embryonic SCs versus the negative controls are
statistically significant. Whilst the difference between the quiescent adult SCs compared with the negative controls is not. On
examination of AP usage, no difference was observed between SCs and the controls. However, comparing the subsets of SC
type with the controls, the quiescent adult SCs are found to up-regulate a larger proportion of genes that have APs compared
to the controls and the converse is true for the proliferating adult SCs and the embryonic SCs.
Conclusions/Significance: These findings suggest that looking at features associated with control of transcription is a
promising future approach for characterizing ‘‘stemness’’ and that further investigations of stemness could benefit from
separate considerations of different SC states. For example, ‘‘proliferating-stemness’’ is shown here, in terms of promoter
usage, to be distinct from ‘‘quiescent-stemness’’.
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Introduction
Stem cells (SCs) have extensive self-renewal capacity and can
differentiate into a wide variety of cell types. These are the two
defining properties that distinguish SCs from fully differentiated
cells. Also central to the study of SCs is the concept of ‘‘stemness’’,
a term coined by biologists to refer to the common genes and
mechanisms regulating SC function [1]. Stemness has proved to
be an elusive concept to define in terms of individual genes and
this has been attributed to the differences in experimental
conditions such as the starting SC population and purity [2,3].
Given that SCs share similar properties, it still remains an
attractive proposition to search for the common biological themes
and regulatory mechanisms controlling SC function. Whilst much
progress has been made to understand the molecular basis of SC
function, the description of the molecular control mechanisms
common to SCs and to given SC types is incomplete. These are
some of the bottle necks that prevent the use of SCs in the
treatment of a wider range of diseases.
Complete information regarding the control of gene expression in
SCs is necessary to understand the regulation of self–renewal and
differentiation. A large number of experiments have shown that the
methylation of promoter CpG-islands and histone modifications
have an important role in gene silencing and play a central role to
genomic imprinting [4,5]. To exemplify the role of CpG-islands in
the control of mouse embryonic SC gene expression, bivalent
domains have been characterized as specific modification patterns
comprising larger regions of H3 lysine 27 methylation containing
smaller regions of H3 lysine 4 methylation [6]. In the genome these
bivalent domains largely correlate with the mammalian conserved
non-coding elements, the CpG-islands and the transcription factor
genes [6]. Bernstein and co-workers (2006) propose that bivalent
domains have a role in silencing genes in embryonic SCs ‘‘while
keeping them poised for activation’’. The methods used include
histone methylation experiments and bioinformatics techniques.
Whilst the role of these domain features has been characterized in
embryonic SCs, very little is known about the adult SCs where few
such studies have been carried out [7,8].
Here, a novel meta-analysis of microarray gene expression data
to investigate the properties of promoters of up-regulated genes in
mouse SCs is described (Fig 1). The promoters of genes are
characterized in broad terms such as being CpG-rich or CpG-
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(SP) or has alternate promoters (APs). A widely accepted definition
of a CpG-island is a genomic region which is longer than 200 bp
with high (G+C) content (.50%) and a ratioof observed to expected
CpG-dinucleotide greater than that typically found in the genome
(.0.6) [9]. The observed versus expected ratio of CpG is normally
suppressed in mammalian genome (<0.1). CpG-islands are in and
near approximately 40% of promoters of mammalian genes and
with respect to actual frequenciesof CpG-islands,the mousegenome
contains about 15,500 whilst that of human contains about 27,000
[10]; the mouse genome has about a 40% decrease in the number of
CpG-islands compared with the human genome.
Figure 1. A schematic describing the work flow of the analysis.
doi:10.1371/journal.pone.0002712.g001
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upstream of the transcriptional start site and is defined by the 59
end of an mRNA transcript. It is a regulatory region that binds the
transacting factors required to control gene transcription. A gene
has APs if it has multiple transcripts that differ in their 59 termini
[11,12]. Recent studies estimate that the percentages of genes
controlled by APs in mouse and human are 28% and 52%
respectively [13]. It is widely accepted that APs are used to drive
tissue-specific gene expression, gene expression in development
and differentiation processes. AP usage contributes also to the
complexity of the mammalian proteome through the generation of
different proteins [11–15]. An understanding of the SC tran-
scriptome is an important step to understanding the mechanisms
regulating biological properties of SCs. Studies that examine the
promoters of active genes in SCs are sparse in the scientific
literature. There are very few scientific research papers investi-
gating the AP usage in SCs. One relevant and recent study based
on ChIP-chip analyses of promoters compared mouse embryonic
SCs with fully differentiated tissue and estimated that 28% of
genes with RNA polymerase II binding utilize APs [16].
One of the aims of this meta-analysis is to quantify the promoter
CpG-richness and AP usage of up-regulated genes in embryonic
SCs and establish if it is similar to that of adult SCs. The SCs
included in this study originate from different sources (eg.,
embryonic SCs, neural SCs, retinal SCs, haematopoetic SCs
and satellite SCs). Quiescent adult SCs and proliferating adult SCs
are included. The microarray gene expression data generated
from five independent research groups are reviewed (Table 1).
This study focuses on the up-regulated genes in mouse SCs and
not human SCs due to differences in the number of CpG-islands
between human and mouse [10], the significant species differences
that occur in the AP usage between mouse and human [13] and
the absence of equivalent human SC molecular profiling studies.
Methods
The methods consist of four parts (Fig 1). The first part involves
extracting the lists of up-regulated genes in SCs from various
microarray studies (Table 1). The second part classifies the
promoters of up-regulated SC genes to belong to one of four
types–CpG-rich AP, CpG-poor AP, CpG-rich SP and CpG-poor
SP [as defined in 15]. The third part identifies AP usage of up-
regulated SC genes by extracting the promoter sequences from
transcripts of genes in the Ensembl database [22,23] using
bioinformatics tools to assess for promoter CpG-richness. The
fourth part describes over-represented gene ontology (GO)
categories determined for the up-regulated SC genes based on
their promoter classification.
Collecting Lists of Up-regulated Genes in Stem cells
The gene lists collated are up-regulated genes for various types
of SCs published by five different research groups (Table 1). The
details for each gene list were obtained from the supplementary
data of the published research. There are 18 data sets classed by
cell type or developmental stage (Table 1). Three different sets of
gene lists are collated as negative controls (Table 2). These
control data sets are obtained from different analyses. The first set
comprises profiled gene expression from 45 mouse samples across
a diverse array of tissues, organs and cell lines [21] and also mouse
mature blood cells [18]. The second set of gene lists comprises
either 10% or 15% of mouse genes from mgu74av2 chip randomly
sampled and were derived as part of this analysis. The third set of
control gene lists comprises the mouse identifiers in the Baek et al
(2007) study [15].
Classifying Promoters of Up-Regulated SC Genes using
the Baek et al Data
Baek and co-workers (2007) characterized 12,025 promoter
regions that are conserved between mouse and human. Of these,
1080couldbereliablyassignedasAPsand3109asSPs.Theyclassed
each promoter as ‘‘CpG-rich’’ if the flanking genomic region
significantly overlaps one or more CpG-islands or as ‘‘CpG-poor’’
otherwise. According to their classification scheme, the properties of
up-regulated SC genes in the four promoter classes (CpG-rich AP,
CpG-poor AP, CpG-rich SP and CpG-poor SP) are considered.
This section describes the mapping of up-regulated SC genes
(Table 1) to previously characterized genes and their promoters in
mouse and human [15]. The promoters and the corresponding
genes (ie., the mouse and human isoforms) are identified by the
RefSeq names and the EMBL/DDBJ/GenBank accession numbers
[15]. Some mouse isoforms are referenced by the MGI Clone
identifiers. To be able to identify common genes between the two
different typesofdata sets, ie.,the datafrom Baek etalstudy [15] and
from our study, it was necessary to obtain three types of identifiers
(the accession number, the RefSeq name and the MGI Clone
identifier) for each mouse probe (Table 1). The accession numbers
and the RefSeq identifiers were extracted for the probes using
Bioconductor [24]. A pipeline was designed to identify the MGI
Clone identifier for mouse probes. The pipeline uses two files
(MGI_EntrezGene.rpt and MGI_CloneSet_RIKEN.rpt) from the
MGI Data andStatisticalReportsFTP Siteftp://ftp.informatics.jax.
org/pub/reports/index.html. The pipeline included the following
three steps. (a) Mapping the probe identifier to the Entrez Gene
identifier using Bioconductor functions; Bioconductor version 2.0
and R version 2.5.0 were used. (b) Mapping the Entrez Gene
identifier to the MGI Marker identifier. (c) Mapping the MGI
Marker identifier to the MGI Clone identifier. These processes are
automated with PERL scripts developed in-house. Lastly, a set of
java classes was developed to compare the RefSeq identifiers, the
accession numbers and the MGI Clone identifiers between the up-
regulated SC genes (Table 1) and the genes from the Baek et al
(2007) study [15].
Classifying Promoters of Up-Regulated SC Genes using
Bioinformatics
The entrez gene identifiers of up-regulated SC genes (Table 1)
were used to extract 1500 bp upstream and 1500 bp downstream of
genomic sequence from the transcription start site. The promoter
regions were extracted from the Ensembl database using the PERL
Ensembl API [22,23]. The NCBI m37 assembly of the mouse
genome was used (Ensembl gene build Oct 2007; database version
48.37a; Ensembl PERL API release 48). A PERL algorithm was
developed to define APs. For each gene, the coordinates of the
transcription start sites (TSSs) were extracted using the Ensembl
PERL API. The TSS coordinates were sorted in ascending order. A
genome wide study to identify and characterize APs of human genes
was previously carried out using the clustering of capped full length
cDNAs and comparing the clusters with the genome sequence and
known RefSeq genes. This study provides strong evidence that the
true APs are most likely to be separated by at least 500 bp [25]. The
APs were identified in this analysis here using a similar definition to
previousstudieswith respecttobeingatleast500 bpapartfromeach
other [15,25]. The most 59 terminal TSS(i) was used as the reference
point to search for a downstream TSS(i+1) which passes the filter. If a
new TSS(i+1) was identified, it was taken as the updated reference
point to search for the next downstream TSS(i+2) and so on until no
more could be found. All the promoter sequences were extracted
from Ensembl and used as input for an EMBOSS program [26]
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5.0.0 was used. Each gene is described as having a SP or APs. Each
gene is described as CpG-rich, CpG-mixed or CpG-less. CpG-rich
describe the scenario in which all the promoters for the gene have a
CpG-island. A gene is CpG-less when none of the promoters have
CpG-islands.AgenebelongstotheCpG-mixedcategorywhenithas
APs and at least one promoter has CpG-islands and at least one
promoter has none. PERL programs were written to perform these
classifications.
Over-Represented GO Terms in the Different Categories
of Data
Two comparisons were performed. GOstats [27], a Bioconductor
packagewritteninR,wasusedtoexaminegeneontology(GO)terms
[28] that are statistically over-represented in the various data sets
(Tables1,2)and thepromotercategories(Fig2).Over-represented
GO terms for given data sets were calculated using a classical hyper-
geometric statistical comparison against a reference gene list using
GOstats. The up-regulated genes expressed in mouse SCs were
compared with the genes present on the microarray chip on which
the experiment was carried out. The GO term identifiers were
includedinthestudyifthey arepresentinthe microarraychipwith a
frequency higher than 8 and if the GO term identifier is present with
a frequency equal to or higher than 8 (out of the 24 data sets). Over-
represented GO terms for genes that belong to a given promoter
class were calculated using a reference gene list. The reference gene
list is the member genes of the four promoter classes plus the
unclassified genes. The GO term identifiers were included in the
study if they are present in the reference gene list and if the GO term
identifier is present with a frequency equal to or higher than 6 (out of
the 24 data sets). The Baek_mm data set was excluded (Table 2).
Table 1. The up-regulated gene lists from the 18 different SC microarray experiments included in the meta-analysis.
Data set Description
Number of
Genes Reference, species and microarray chip
Ramalhosantos_ESC ESCs 1788 Ramalho Santos et al 2002 [17] (mouse; mgu74av2)
Ramalhosantos_NSC Adult NSCs 2458
Ramalhosantos_HSC Adult HSCs 1977
Fortunel_ESC ESCs 1687 Fortunel et al 2003 [3] (mouse; mgu74av2)
Fortunel_NPC Adult NPCs 1737
Fortunel_RPC Adult RPCs 2230
Ivanova_ESC ESCs 757 Ivanova et al 2002 [18] (mouse; mgu74av2)
Ivanova_NSC Adult NSCs 830
Ivanova_HSC Adult HSCs 908
Venezia_adult_liver_HSC Adult liver HSCs 955 Venezia et al 2004 [19] (mouse; mgu74av2)
Venezia_fetal_liver_HSC Fetal liver HSCs 817
Venezia_5FU Genes that change over 5FU time course 1488
Venezia_pgp Genes expressed on day (2,3 & 6) after 5FU treatment 680
Venezia_psig Gene expressed (Venezia fetal liver>Venezia_pgp) 338
Venezia_qgp Gene expressed on day (0,1,10 & 30) after 5FU treatment 808
Venezia_qsig Genes expressed (Venezia adult HSCs>Venezia_qgp) 298
Fukada_Satellite_Proliferating Activated satellite cells in adult skeletal muscle 507 Fukada et al 2007 [20] (mouse; moe430)
Fukada_Satellite_Quiescent Quiescent satellite cells in adult skeletal muscle 659
The key to abbreviations: SC - stem cell; ESC - embryonic SC; HSC - haematopoietic SC; NSC - neural SC; NPC - neural progenitor cell; RPC - retinal progenitor cell. The
pyrimidine analog 5-fluorouracil (5FU) kills cycling HSCs. The spared quiescent HSCs go into cycle after 5FU treatment to re-populate and this is analyzed in the form of
a time series [19]. In Figs 2 & 5 venezia_adult_liver is equivalent to venezia_adult_liver_HSC.
doi:10.1371/journal.pone.0002712.t001
Table 2. The seven negative control sets included in the meta-analysis.
Data set Description Number of genes Reference, species and microarray chip
Suai_mm Differentiated tissue–42 tissue types 256 Su et al 2002 [21] (mouse;mgu74a)
Ivanova_MBC_mgu74av2_2 Mature Blood Cells 224 Ivanova et al 2002 [18] (mouse; mgu74av2)
Random_mgu74av2_2 ,10% of chip sampled 1250 Generated in this study (mouse; mgu74av2)
Random_mgu74av2_15P1 ,15% of chip sampled 1900
Random_mgu74av2_15P2 ,15% of chip sampled 1900
Random_mgu74av2_15P3 ,15% of chip sampled 1899
Baek_mm Transcripts with promoters categorized (mouse) 4189 Baek et al 2007 [15] (mouse;na)
The key to abbreviation: na - not applicable.
doi:10.1371/journal.pone.0002712.t002
A Meta-Analysis of Stemness
PLoS ONE | www.plosone.org 4 July 2008 | Volume 3 | Issue 7 | e2712For both comparisons, the entrez gene identifiers were used for gene
identification. A PERL script was written to automate this process
and perform this analysis.
Results
Classifying Promoters of SC Genes using the method
outlined in Part 2 (Fig 1)
The genes are categorised to have one of four promoter types
according to the Baek et al scheme (CpG-rich AP, CpG-poor AP,
CpG-rich SP and CpG-poor SP) (F i g2 ;F i gS 1 ). This scheme
considers genes and promoter sequences conserved in human and
mouse. The key findings are discussed in the following six
subsections.
(1) In comparison with the controls, the SCs have a higher
proportion of genes using the CpG-rich SPs and a lower
proportion of genes using the CpG-poor SPs. Comparing
the SCs and the controls, the differences in the CpG usage
are confined to the SP categories and not the APs. (i) The
SCs (mean=72.9%) have a higher proportion of up-regulated
genes with CpG-rich SPs compared with the negative controls
(mean=59.5%) (Table 3; Fig 2C). (ii) The SCs (mean=4.2%)
have a lower proportion of up-regulated genes with CpG-poor SPs
compared with the negative controls (mean=16.2%) (Table 3;
Fig 2D). (iii) The SCs (mean=18.6%) have similar proportions of
up-regulated genes with CpG-rich APs compared to the negative
controls (mean=18.1%) (Table 3; Fig 2A). (iv) The SCs
(mean=4.2%) have a slightly lower proportion of up-regulated
genes with CpG-poor APs compared to the negative controls
(mean=6.2%) (Table 3; Fig 2B). For the two alternate promoter
categories (CpG-rich AP and CpG-poor AP), the percentage of
genes in the SCs compared to the negative controls differs by less
than 2.0%. This difference is small and statistically insignificant.
The opposite is true for the SP categories (CpG-rich SP and CpG-
poor SP) where the difference between SCs and non SCs is large
and statistically significant (Table 4).
(2) The embryonic SCs and the proliferating adult SCs
use a higher proportion of CpG-rich SPs compared with the
controls and the quiescent adult SCs. (i) The proliferating
adult SCs (mean=87.3%) have the highest proportion of up-
regulated genes using CpG-rich SPs closely followed by the
embryonic SCs (mean=78.7%) and thirdly by the adult SCs
(mean=70.7%). These three SC types use the CpG-rich SPs to a
greater extent compared with the quiescent adult SCs and the
negative controls (Table 5; Fig 2C). The quiescent adult SCs
(mean=56.8%) and the negative controls (mean=59.5%) are
similar in their use of the CpG-rich SPs. High usage of the CpG-
rich SPs is defined as a property of the embryonic SCs and the
proliferating adult SCs (Table 6). (ii) The proliferating adult SCs
(mean=2.4%), the embryonic SCs (mean=3.4%), the adult SCs
(mean=4.1%) and the quiescent adult SCs (mean=7.6%) are in
consensus with respect to the usage of CpG-poor SPs. All four SC
types use this promoter class to a lower extent compared with the
negative controls (mean=16.2%). All SC types are statistically
similar with each other and statistically differ from the non SCs
(Table 5; Fig 2D). Examining the individual percentages and
with the exception of 2 outliers namely, ivanova_HSC_mgu74av2
and fukada_satellite_Q, all the SCs have less than 7% usage of
Figure 2. The distribution of genes classed according to the four promoter types (A) CpG-rich AP, (B) CpG-poor AP, (C) CpG-rich SP
and (D) CpG-poor SP. The standard error for the percentages are calculated using the equation (p*(1002p)/n)
0.5 where p is the percentage of
genes that belong to a given promoter type and n is the total number of genes classified. The standard errors for the percentages are plotted as error
bars. See Fig S1.
doi:10.1371/journal.pone.0002712.g002
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as a property of stemness (Tables 4, 6).
(3) The quiescent adult SCs up-regulate a higher
proportion of genes that have CpG-rich APs compared to
the controls and the proliferating adult SCs. (i) The
quiescent adult SCs (mean=26.8%) differ in their use of the
CpG-rich APs compared with the proliferating adult SCs
(mean=9.6%), the embryonic SCs (mean=15.6%) and the
negative controls (mean=18.1%) (Fig 2A; Tables 6, 7). (ii)
The embryonic SCs (mean=2.3%) and the proliferating adult SCs
(mean=0.7%) are similar in that they use the CpG–poor APs
minimally compared with the adult SCs (mean=4.7%), the
quiescent adult SCs (mean=8.9%) and the negative controls
(mean=6.2%) (Fig 2B; Table 7). The two adult SC states
(quiescent and proliferating) are observed to have distinct patterns
in promoter usage. With respect to the CpG-rich AP usage, the
quiescent adult SCs are similar to the negative controls and both of
these differ from the embryonic SCs and the proliferating adult
SCs. With respect to the CpG-poor AP usage the converse is true,
the proliferating adult SCs and the embryonic SCs are similar to
the negative controls and these three differ statistically from the
quiescent adult SCs.
(4) CpG-islands are found in the promoters of active genes
in SCs more often than in the controls. The AP and the SP
classes are merged so the CpG-rich(CpG-rich SPand CpG-richAP)
and the CpG-poor (CpG-poor SP and CpG-poor AP) classes are
considered (Fig 3A; Tables 8, 9). (i) The SCs (mean=91.6%) have
a higher proportion of up-regulated genes using the CpG-rich
promoters compared with the negative controls (mean=77.6%).
There is a large difference (,15%) between the two means which is
statistically significant (Table 8). The proliferating adult SCs
(mean=96.9%), the embryonic SCs (mean=94.3%), the adult
SCs (mean=91.2%) and the quiescent adult SCs (mean=83.5%)
make higher use of the CpG-rich promoters compared with the
negative controls (mean=77.6%). The first three comparisons show
statistically significant differences compared to the negative controls
(Table 9) and the fourth comparison (ie., the quiescent adult SCs
versus the negative controls) is not statistically significant. The
proliferating adult SCs (mean=96.9%) use a higher proportion of
up-regulated genes with CpG-rich promoters than the quiescent
adult SCs (mean=83.5%). (ii) The adult SCs differ from the
embryonic SCs and the proliferating adult SCs by a small value (less
than 6%) which is statistically significant (Table 9). High usage of
CpG-rich promoters is essentially a property of the embryonic SCs
and the proliferating adult SCs.
(5) There is no difference in the AP usage between SCs and
thecontrols. Thesingle(CpG-richSPandCpG-poorSP)andthe
alternative (CpG-rich AP and CpG-poor AP) promoter types
(Fig 3B; Table 8) are considered. The difference in the
percentage of genes using APs in the SCs and the negative
controls is small (less than 2.0%) and statistically insignificant
(Tables 4, 8).
(6) The quiescent adult SCs up-regulate a larger proportion
of genes that have APs compared with the controls and the
Table 3. The distribution of promoter usage in the SCs and
the negative controls (NCs); four promoter categories are
shown.
Promoter type Mean6Standard Deviation P-value
SC NC
CpG-rich AP 18.6267.57 18.1262.81 0.8106
CpG-poor AP 4.2162.85 6.1962.32 0.0941
CpG-rich SP 72.93612.00 59.5067.16 0.00288
CpG-poor SP 4.2462.94 16.1865.88 0.001240
P-values calculated using the Welch two sample t-tests. The promoters are
characterized using the Baek et al (2007) scheme.
doi:10.1371/journal.pone.0002712.t003
Table 5. The distribution of promoter usage in the SC types and the negative controls (NCs); the upper right section of the table
considers the CpG-rich SPs and the lower left section considers the CpG-poor SPs.
*************** ASC (70.7368.63) ESC (78.7265.53) PASC (87.2969.01) QASC (56.7566.93) NC (59.5067.16) ***************
ASC (4.1162.89) *************** 0.08415 0.05993 0.04319 0.01649 ASC (70.7368.63)
ESC (3.3960.78) 0.5229 *************** 0.2384 0.01210 0.001145 ESC (78.7265.53)
pASC (2.3561.81) 0.2732 0.4329 *************** 0.01123 0.01596 pASC (87.2969.01)
qASC (7.5864.03) 0.2714 0.2107 0.1402 *************** 0.6 qASC (56.7566.93)
NC (16.1865.88) 0.0009633 0.001057 0.0005378 0.03875 *************** NC (59.5067.16)
*************** ASC (4.1162.89) ESC (3.3960.78) pASC (2.3561.81) qASC (7.5864.03) NC (16.1865.88) ***************
P-values calculated using the Welch two sample t-tests. The promoters are characterized using the Baek et al (2007) scheme. The key to the abbreviations: ESC -
embryonic SC; ASC - adult SC; qASC - quiescent adult SC; pASC - proliferating adult SC; NC - negative control. The first and the last rows and columns provide the SC
type and the mean6the standard deviation are given in parenthesis.
doi:10.1371/journal.pone.0002712.t005
Table 4. The promoter usage in the SCs compared with the
negative controls.
AP SP
CpG-rich < .
CpG-poor < ,
doi:10.1371/journal.pone.0002712.t004
Table 6. The promoter usage in the quiescence SCs
compared with the proliferating SCs.
AP SP
CpG-rich .. ,,,
CpG-poor . <
doi:10.1371/journal.pone.0002712.t006
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the table shows the CpG-rich APs and the lower left section the CpG-poor APs.
*************** ASC (20.4366.28) ESC (15.6365.16) PASC (9.6366.51) QASC (26.7963.85) NC (18.1262.81) ***************
ASC (4.7361.02) *************** 0.1989 0.07734 0.08772 0.3703 ASC (20.4366.28)
ESC (2.2760.96) 0.005404 *************** 0.2630 0.02206 0.4211 ESC (15.6365.16)
pASC (0.7360.74) 0.0007444 0.06135 *************** 0.02536 0.1438 pASC (9.6366.51)
qASC (8.8762.04) 0.06095 0.01845 0.01236 *************** 0.03970 qASC (26.7963.85)
NC (6.1962.32) 0.1607 0.003795 0.0005364 0.1361 *************** NC (18.1262.81)
*************** ASC (4.7361.02) ESC (2.2760.96) pASC (0.7360.74) qASC (8.8762.04) NC (6.1962.32) ***************
P-values calculated using the Welch two sample t-tests. The promoters are characterized using the Baek et al (2007) scheme. The notes for Table 5 provide further
explanations.
doi:10.1371/journal.pone.0002712.t007
Figure 3. The percentage of the genes classed according to the promoter type. The promoters are characterised based on the Baek et al
2007 scheme. Consideration is given to (A) the genes using CpG-rich and CpG-poor promoters and (B) the genes with single and alternative
promoters.
doi:10.1371/journal.pone.0002712.g003
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(mean=35.7%) have a higher proportion of up-regulated genes
using the APs compared to the controls (mean=24.3%), the
proliferating adult SCs (mean=10.4%) and the embryonic SCs
(mean=17.9%) (Fig 3B; Tables 6, 9). These differences are
appreciable and statistically significant. Additionally, in the adult
SCs, AP usage is reduced by 10.5% compared with the quiescent
adult SCs and increased by 14.8% compared with the proliferating
adult SCs. Both these differences are statistically significant.
Classifying Promoters of SC Genes using the method
outlined in Part 3 (Fig 1)
This second study is based on mouse genes and the property of
conservation is not given consideration. The promoter sequences
of mouse SC genes were extracted from Ensembl and char-
acterised in terms of CpG-islands and APs using the Bioinfor-
matics analysis outlined in part 3 of methods (Fig 1).
(1) CpG-islands are found in the promoters of active
genes in SCs more often than in the controls. The
promoters of genes that are CpG-rich and CpG-poor are
considered in the context of SCs and non SCs (Fig 4A;
Tables 10, 11). The SCs (mean=41.3%) have a higher
proportion of up-regulated genes using the CpG-rich promoters
compared with the negative controls (mean=34.2%). There is
approximately 6% difference between the two means and this
difference is statistically significant (Table 10).
(2) In terms of CpG-islands in the promoters of genes, the
embryonic and the proliferating adult SCs use a higher
proportion of genes with these promoter types than the
controls whilst the quiescent adult SCs are similar to the
controls. One of the aims of the investigation is to quantify the
usage of CpG-rich promoters of up-regulated genes in the
embryonic SCs and establish if this property is similar to that of
the adult SCs. The proliferating adult SCs (mean=42.0%), the
embryonic SCs (mean=42.8%), the adult SCs (mean=41.7%)
and the quiescent adult SCs (mean=37.5%) make higher use of
the CpG-rich promoters compared with the negative controls
(mean=34.4%). The first three data sets show statistically
significant differences compared with the negative controls
(Table 11). However the fourth SC data set - the quiescent
adult SC compared with the negative controls exhibits no
statistically significant difference. Whilst statistically significant
differences are not observed between the different SC types,
statistically significant differences are observed with the SCs versus
the negative controls for three out of the four SC types.
(3) There is no difference in the AP usage between the SCs
and the controls. Each gene is classed as having either a SP or
APs and the differences in usage is described for the SCs and non
SCs (Fig 4B; Table 10). The difference in the percentage of
genes with APs in the SCs and the negative controls is small (less
than 1%) and statistically insignificant (Table 10).
(4) The quiescent adult SCs up-regulate a larger proportion
of genes that have APs compared with the proliferating adult
SCs. The quiescent adult SCs (mean=22.6%) have a higher
proportion of up-regulated genes using the APs compared with the
proliferating adult SCs (mean=15.2%) and the embryonic SCs
(mean=19.0%).Boththesecomparisonsshowstatisticallysignificant
differences (Fig 4B; Table 11).
Comparing the results obtained from the two
classification schemes
This section compares and contrasts the results obtained from
the two classification schemes (parts 2 and 3 of work flow; Fig 1).
The Baek et al classification is based on the promoters and the
genes conserved in mouse and human. The second study is based
on mouse genes and the property of conservation is not given
consideration. When the genes and the promoters are conserved in
human and mouse, both SC and non SC populations have double
the proportion of genes that are CpG-rich than when conservation
is not considered (Figs 3, 4; Tables 8, 10). Considering the
differences between the SC and the non SC populations in each
study, 14.0% (91.6–77.6%; Table 8) and 6.1% (41.3–34.2%;
Table 10) more SC genes have CpG-islands compared to the non
SC populations using the classification scheme of Baek et al (2007)
and the scheme based on the data extracted from Ensembl and
newcpgreport annotations respectively (Fig 1). The difference
between both SCs and non SC populations again is increased by a
factor of 2 when the genes and the promoters are conserved in
Table 8. The distribution of promoter usage in the SCs and
the negative controls (NCs); CpG-richness and AP usage are
considered.
Promoter type Mean6Standard Deviation P-value
SC NC
CpG-rich 91.5665.37 77.6267.30 0.001455
AP 22.8369.92 24.3264.00 0.5986
P-values calculated using the Welch two sample t-tests. The promoters are
classified using the Baek et al (2007) scheme. The notes for Table 5 provide
further explanations.
doi:10.1371/journal.pone.0002712.t008
Table 9. The distribution of promoter usage in the different SC types and the negative controls (NCs); the upper right section of
the table considers CpG-richness, whilst the lower left section considers AP usage.
*************** ASC (91.1663.55) ESC (94.3561.20) PASC (96.9262.51) QASC (83.5466.08) NC (77.6267.30) ***************
ASC (25.1666.95) *************** 0.04634 0.02793 0.1502 0.001849 ASC (91.1663.55)
ESC (17.9065.54) 0.08772 *************** 0.2094 0.08717 0.0007531 ESC (94.3561.20)
pASC (10.3667.21) 0.04471 0.2126 *************** 0.04675 0.0002692 pASC (96.9262.51)
qASC (35.6664.25) 0.02222 0.004974 0.01117 *************** 0.2462 qASC (83.5466.08)
NC (24.3264.00) 0.7759 0.09962 0.06397 0.02046 *************** NC (77.6267.30)
*************** ASC (25.1666.95) ESC (17.9065.54) pASC (10.3667.21) qASC (35.6664.25) NC (24.3264.00) ***************
P-values calculated using the Welch two sample t-tests. The Baek et al (2007) classification scheme is used. The notes for Table 5 provide further explanations.
doi:10.1371/journal.pone.0002712.t009
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Based on the classification scheme of Baek et al (2007) and the
scheme outlined in part 3 (Fig 1) respectively, 1.5% (24.3–22.8%;
Table 8) and 0.6% (20.5–19.9%; Table 10) of genes have APs
when comparing SCs to the non SC populations. These are small
differences and neither are significant. In both studies, the
quiescent adult SCs up-regulate a larger proportion of genes that
have APs compared to the proliferating adult SCs (Tables 9, 11).
Based on the classification scheme of Baek et al (2007) and the
scheme outlined in part 3 (Fig 1) respectively, 15.3% (35.7–10.4%;
Table 9) and 6.3% (22.6–15.3%; Table 11) a larger proportion
of genes make use of APs in the quiescent adult SCs compared to
the proliferating adult SCs.
The trends obtained from the two classification schemes (parts 2
and 3 of work flow; Fig 1) are complementary and supportive.
However, the trends are emphasized in the first study compared to
the second study. This is most likely due to the conservation of the
promoters and the genes in human and mouse in the first study
which is not considered in the second study. Conserved non-
coding DNA sequences are found near genes involved in early
development processes and transcriptional control. The conserved
non coding sequences are enriched with regulatory regions such as
promoters and enhancers [29]. These regions are enriched with
CpG-islands and other regulatory signals for control mechanisms
and this observation supports the ethos that conserved genes that
have conserved promoters are most likely to share common
Figure 4. The percentages of the genes classed according to the promoter type. The promoters are characterised using the Bioinformatics
methods outlined in part 3 (Fig 1). The y-axis reports the percentage of genes using (A) CpG-rich promoters and (B) APs whilst the x-axis reports the
data sets analysed (Tables 1, 2).
doi:10.1371/journal.pone.0002712.g004
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when taking into account what is known about early develop-
mental processes in mammals and also transcriptional control
processes [6,29]. Lastly, the second study shows estimates of CpG-
islands and alternate usage of a similar order of magnitude
predicted in the mouse genome [10,13,16].
Over-Represented GO Terms in the Different Categories
of Data
Over-represented GO terms in up regulated genes in mouse
stem cells are examined. Two main studies are carried out. The
first takes a bird’s eye view of the relationships between over-
represented GO terms and various stem cell types. The second
study shows associations between over-represented GO terms and
the four different promoter types up-regulated in mouse SCs.
Over-Represented GO Terms associated with SC Types
Clustering the up-regulated genes in mouse SCs based on the
over-represented GO term identifiers clusters the data into three
groups (Fig 5; Table 12). The first contains the proliferating adult
SCs and the embryonic SCs, the second comprises the quiescent
adult SCs and the third contains the negative controls (Fig 5).
There are a few exceptions. For example, the ivanova_ESC data
clusters with the quiescent adult SCs and a few adult SCs
(proliferating and quiescence status unknown) cluster in one of the
three groups. The over-represented GO term identifiers in the
embryonic SCs and the proliferating adult SCs are associated with
mitosis (the mitotic cell cycle, DNA replication and DNA repair),
meiosis (the meiotic cell cycle and DNA recombination), DNA
packaging (any process by which DNA and associated proteins are
formed into a compact, orderly structure) and the generation of
the nucleotide building blocks (Table 12). RNA splicing, mRNA
processing, translation, protein folding, protein targeting and more
general categories are amongst the over-represented terms. The
over-represented GO term identifiers in the quiescent adult SCs
are associated with regulation: that is the regulation of cell cycle,
DNA dependent transcription, metabolic processes and cellular
processes. The two over-represented GO terms, not associated with
regulation, are transcription and RNA biosynthetic process
(Table 12). The quiescent adult SCs are enriched with GO terms
associated with regulation, whereas the proliferating adult SCs and
the embryonic SCs focus on GO terms that are more general in
scope. To exemplify, the nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process (GO:0006139) is used. This GO term
is over-represented in the cluster containing the proliferating adult
SCs and the embryonic SCs. Whilst, the regulation of nucleobase,
nucleoside, nucleotide and nucleic acid metabolic process
(GO:0019219) is over-represented in the quiescent adult SCs.
Additionally, this GO term is part of the nucleobase, nucleoside,
nucleotide and nucleic acid metabolic process. This suggests that the
proliferating adult SCs and the embryonic SCs are associated with
the higher order GO terms that include the regulation and suggests
that the quiescent adult SCs are focussed on the regulation of this
process. Similar analogies exist with the cell cycle GO terms.
The following functional categories are enriched in HSCs,
NSCs and ESCs: signalling, transcriptional regulation, DNA
repair, cell cycle regulation, cell death, RNA processing,
translation, protein folding, ubiquitin pathway, vesicle traffic and
toxic stress response [17]. Seven out of the eleven GO terms are
over-represented here (Table 12) whilst the remaining (4/11) GO
terms (signalling, vesicle traffic, cell death and toxic response) are
not over-represented (Table 12). In the study of Ivanova et al
(2002), the following functional groups were identified in HSCs
(metabolism, RNA binding proteins, apoptosis, protein processing,
protein folding, protein synthesis, DNA repair, cell cycle,
transporters, cytoskeletal proteins, ECM/cell adhesion, chromatin
regulators, transcription factors, intracellular signalling, surface
antigens, cell surface receptors and ligands) [18]. Eight out the
seventeen GO terms are over-represented here (Table 12) whilst
the remaining nine GO terms (RNA binding proteins, transport-
ers, cytoskeletal proteins, ECM/adhesion, intracellular signalling,
surface antigens, cell surface receptors, apoptosis, ligands), are not
over-represented here (Table 12). The Ivanova et al (2002) study
scores functional categories based on counts of genes with the
Table 10. The distribution of promoter usage; CpG-richness
and AP usage are considered to highlight differences between
SCs and non SCs.
Promoter type Mean6Standard Deviation P-value
SC NC
CpG-rich 41.3363.48 34.1562.44 0.0001072
CpG-less 53.5263.07 59.6562.61 0.0007695
CpG-mixed 5.1561.79 6.2060.68 0.04948
AP 19.8963.20 20.5261.88 0.5677
P-values calculated using the Welch two sample t-tests. The promoter
classifications rely on the methods described in part 3 (Fig 1). The notes for
Table 5 provide further explanations.
doi:10.1371/journal.pone.0002712.t010
Table 11. The distribution of the promoter usage in the different SC types and the negative controls (NCs); the upper right section
of table considers CpG-richness, whilst the lower left section considers the AP usage.
*************** ASC (41.7863.29) ESC (42.8461.76) PASC (41.9663.08) QASC (37.4764.78) NC (34.1562.44) ***************
ASC (21.0562.35) *************** 0.4831 0.9351 0.2536 0.0003197 ASC (41.7863.29)
ESC (19.0061.92) 0.1471 *************** 0.6879 0.1826 0.0001927 ESC (42.8461.76)
pASC (15.2563.26) 0.07146 0.1731 *************** 0.2542 0.02616 pASC (41.9663.08)
qASC (22.6361.08) 0.1668 0.02622 0.04777 *************** 0.3527 qASC (37.4764.78)
NC (20.5261.88) 0.6467 0.2580 0.09029 0.07264 *************** NC (34.1562.44)
*************** ASC (21.0562.35) ESC (19.0061.92) pASC (15.2563.26) qASC (22.6361.08) NC (20.5261.88) ***************
P-values calculated using the Welch two sample t-tests. The promoter classifications rely on the Bioinformatics methods described in part 3 (Fig 1). The notes for
Table 5 provide further explanations.
doi:10.1371/journal.pone.0002712.t011
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study investigates over-representation using a hyper geometric
model and employs a degree of consensus across multiple SC
types. The Venezia et al study (2004) resulted in the following GO
enrichments in HSCs (proliferating; ATP synthesis coupled
electron transport, DNA replication, cell cycle check point and
hydrogen transport: quiescent; regulation of cell cycle, defense
response, protein kinase cascade, cell-cell adhesion) [19]. Four out
of these were identified here (Table 12). The Fukada et al study
(2007) resulted in the following GO enrichments in satellite cells
(proliferating; synthesis of DNA, RNA, protein and progression of
cell cycle: quiescent; regulation of cell growth, TM receptor
protein tyrosine phosphatase signalling pathway, cell-cell adhesion)
[20]. Whilst all of the proliferating GO enrichments in the Fukada
et al (2007) study are identified here, none of the quiescent GO
terms are identified (Table 12). The aim of the meta-analyses
here, is to examine commonalities across SCs and SC types. There
are more GO terms over-represented that are specific to given
data sets in our analysis; many of these are not present at
frequencies high enough to pass the filters for consensus (methods).
The differences between the enrichment of GO terms in the five
independent studies plus this study here can be attributed, in part,
to the differences in the methods.
Over-Represented GO Terms associated with the Four
Promoter Types
Comparing the embryonic SCs with the controls, no biological
themes are observed for the GO terms over-represented in the
CpG-rich APs. In three out of the four embryonic SCs, the two
GO terms, the ribonucleoside and the uridine metabolic processes,
are over-represented (Table 13). Comparing the SCs with the
control sets some biological themes are over-represented in the
CpG-poor APs and surprisingly three of the GO terms (the
positive regulation of B-cell proliferation, the non-apoptotic
programmed cell death and the negative regulation of cyclin-
dependent protein kinase activity) are common to all the adult
neural SCs. Comparing the embryonic SCs with the controls, the
GO terms including the mitotic sister chromatid segregation, the
M-phase of mitotic cell cycle, the mitotic cell cycle and mitosis are
over-represented in the CpG-rich SPs. Themes such as the
electron transport and the immune response are over-represented
in the CpG-poor SPs (Table 13). Associations of GO terms with
promoter types were carried out previously [15]. A fair extent of
agreement exists between the types of GO terms established
previously [15] and those identified here. For example, both
investigations identify the GO term immune response with the
CpG-poor SPs. The differences observed could be due to
Figure 5. The over-represented GO terms in up-regulated genes of mouse SCs are shown. A heat map showing dendograms clustering
the GO terms (x-axis) associated with the different SC data sets (y-axis). The dendogram on the x-axis shows clusters of the various data sets into three
main categories. The cluster on the left (x-axis) comprises the negative controls, the cluster in the middle contains the adult SCs and the quiescent
adult SCs and the third cluster on the right (of x-axis) largely contains the embryonic and the proliferating adult SCs. The key to the abbreviations
follow: RS-Ramalho-Santos; Ve-Venezia; Fo-Fortunel; Iv-Ivanova; Ra-Random_mgu74av2; Fu-Fukada. The GO term identifiers are given in Table 12.
doi:10.1371/journal.pone.0002712.g005
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occurring higher in the list for given promoter types and the
predominant use of up-regulated genes in SCs (in this study)
compared with their whole genome study.
Discussion
This present work provides new insights regarding the roles of
non-coding regions of over-expressed genes in SCs; specifically, of
genomic regions in and around gene promoters. We focused our
analysis particularly on CpG-islands and on genes that have APs.
This is the first large scale survey of CpG-richness and AP usage for
up-regulated SC genes. We looked at five independent microarray
investigations of mouse SCs. These comprise 25 data sets, over
25,000genesandover75,000promoters.Itpresentsabroadproofof
concept that new observations can be obtained from the meta-
analysis of published gene lists generated from microarray gene
expression experiments. We show that mining of published gene lists
obtained from the microarray gene expression can be used to probe
underlying patterns of gene regulation. The study uses large volumes
of experimental data, and analyses it in ways that have not been
previously considered; that is, looking for information in non-coding
regions of genes, where previously only the coding regionshave been
considered [2,3]. Thus providing new research directions in
analyzing microarray gene expression data. However, these data
are complex, and there are many challenges in re-analysing the
results of these types of experiments at scale. Some of the challenges
arise because of variations in how the original experiments were
conceived and carried out: that is platform-to-platform [30], lab-to-
lab [2,3] and, of course, species-to-species variability. Other
challenges include the lack of standards (e.g. gene naming) for data
formats, which make data handling problematic and time-
consuming; and critically, important data is sometimes ambiguous
or missing from database submissions and supplementary informa-
tion. This means that authors sometimes need to be contacted to
clarify certain issues with regards to the gene lists. In the present
work, the impact of platform-to-platform variability was minimized,
because much of the data included in the analysis was performed on
the mgu74av2 chip (Tables 1, 2). We eliminated species-to-species
effects by carrying out the entire analysis on mouse SCs. Problems
with gene naming were resolved by using the probe identifiers and
entrez gene identifiers as the starting point for the analyses, rather
than the gene names.
Relatively fewer laboratory–based experiments have been
performed on the adult SCs compared with the embryonic SCs,
with respect to DNA methylation and chromatin re-modelling [8].
The focus of research efforts has been on the embryonic SCs
[16,31]. CpG-islands are present in the promoters of up-regulated
genes of the embryonic SCs to a similar extent of that in the
proliferating adult SCs. The up-regulated genes in the embryonic
SCs and the adult SCs (with the exception of the quiescent adult
SCs) use higher proportions of promoters that are CpG-rich than
non-SCs. The results of this investigation suggest that CpG-
richness, whether from a proliferating adult SC or an embryonic
source, is an important feature for regulating gene expression in
SCs. This effect is reduced in the quiescent adult SCs. Our
observations suggest that epigenetic regulatory mechanisms such
as DNA methylation and/or chromatin re-modelling are impor-
tant features in the control of gene expression in the embryonic
SCs and the proliferating adult SCs and that these effects are used
in a different way in the adult quiescent SCs. Stemness has been
defined as an unproven notion [1]. This study brings to the fore
two related issues. Firstly, considering features associated with
control of transcription is a very promising approach for defining
Table 12. Over-represented GO term identifiers in 24 data
sets.
GO IDs Description
Over-represented GO terms
associated with cluster 1
comprising the embryonic SCs
and the proliferating adult SCs
GO:0000279 M phase
GO:0000278 Mitotic cell cycle
GO:0006260 DNA replication
GO: 0006270 DNA replication initiation
GO:0006397 mRNA processing
GO:0007067 Mitosis
GO:0008380 RNA splicing
GO:0006281 DNA repair
GO:0009719 Response to endogenous
stimulus
GO:0006511 Ubiquitin-dependent protein
catabolic process
GO:0006457 Protein folding
GO:0006605 Protein targeting
GO:0043632 Modification-dependent
macromolecule catabolic
process
GO:0051603 Proteolysis involved in
cellular protein catabolic
process
GO:0006412 Translation
GO:0006139 Nucleobase, nucleoside,
nucleotide and nucleic acid
metabolic process
GO:0051301 Cell division
GO:0007126 Meiosis
GO:0051321 Meiotic cell cycle
GO:0065003 Macromolecular complex
assembly
GO:0006310 DNA recombination
GO:0006323 DNA packaging
GO:0043283 Biopolymer metabolic
process
GO:0044238 Primary metabolic process
Over-represented GO terms
associated with cluster 2
containing the quiescent
adult SCs
GO:0019222 Regulation of metabolic
process
GO:0019219 Regulation of nucleobase,
nucleoside, nucleotide and
nucleic acid metabolic
process
GO:0050794 Regulation of cellular process
GO:0065007 Biological regulation
GO:0032774 RNA biosynthetic process
GO:0006350 Transcription
GO:0006355 Regulation of transcription,
DNA-dependent
GO:0000074 Regulation of cell cycle
doi:10.1371/journal.pone.0002712.t012
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Secondly, in terms of stemness it would appear to be more fruitful
to investigate ‘‘proliferating-stemness’’ which is shown here, in
terms of promoter usage, to be distinct from ‘‘quiescent-stemness’’.
Our results show different signatures of promoter usage for the SC
populations and non-SC populations and among different types of
SCs. The results of this research may have possible applications to
establish how pure an adult SC population is, ie., what proportion
of SCs are in cycle; in quiescent it is widely accepted that about 1–
2% of cells are in cycle, whereas in proliferating SCs about 30% of
cells are in cycle [reviewed in 19]. Our devised classification
system might be usefully applied on a gene chip mRNA expression
profile to distinguish whether the cells are SCs or not, and quite
importantly whether adult SCs are quiescent or proliferating.
The quiescent adult SCs are shown to express a higher
proportion of genes that use APs that are CpG-rich compared
with the embryonic SCs, the proliferating adult SCs and the
controls. Put another way, with respect to the alternate promoter
usage, the proliferating adult SCs and the embryonic SCs are
similar to the negative controls, whilst the quiescent adult SCs are
different compared to the negative controls. Whilst the prolifer-
ating adult SCs and the embryonic SCs have a larger proportion
of genes with CpG-rich SPs compared with the controls and the
quiescent SCs. Additionally, the adult SCs (ie., pASCs, qASCs and
ASCs) collectively display more variability in the use of APs than
the embryonic SCs. Usage of the APs versus the SPs in regulating
SC function has not been studied widely. Our results suggest that
the use of the SPs and the APs differs significantly in the different
contexts of the adult SCs. This does make sense in a biological
context. It is generally accepted in the scientific literature that the
APs are more highly regulated than the SPs [15]. The CpG-rich
SP class is the least highly regulated of promoters and linked to
house-keeping functions required by most cell types. The other
three classes CpG-poor SP, CpG-rich AP and CpG-poor AP fall
into classes of highly regulated promoters. In terms of up-regulated
genes using CpG-rich SP class, these results suggest that the
embryonic SCs and the proliferating adult SCs are more active
than the adult quiescent SCs and one of the ways the proliferating
adult SCs and the embryonic SCs achieve this mechanistically, is
by reducing use of the genes that have APs and increasing the use
of genes that have SPs and in particular increasing the use of genes
that have CpG-rich SPs.
The overall aim of this research was to gain new insights into
the biological properties likely to affect SC gene expression. We
designed a novel bioinformatics analysis pipeline and utilized this
pipeline to examine previously published gene expression data
from SCs in a novel way and to a large extent the overall aim of
the meta-analysis was achieved. We were able to provide new
insights into the regulation of SC function. This type of meta-
analysis in future could rely on the gene expression data deposited
in microarray databases such as Array-Express [32] and GEO
[33]. Going down this route would allow for further automation to
include larger numbers of cell types and species types and will
provide for new research directions in analysis of microarray gene
expression data.
Supporting Information
Figure S1 The distribution of genes classed according to the four
promoter types: CpG-rich AP, CpG-poor AP, CpG-rich SP and
Table 13. Over-represented GO term identifiers in the four promoter categories.
Promoter Type GO ID Description Comments
CpG-rich AP GO:0019219 Regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
GO:0006350 Transcription
GO:0032774 RNA biosynthetic process
GO:0006355 Regulation of transcription, DNA-dependent
GO:0016481 Negative regulation of transcription
GO:0046108 Uridine metabolic process
GO:0009119 Ribonucleoside metabolic process
CpG–poor AP GO:0030890 Positive regulation of B cell proliferation In all NSCs
GO:0016244 Non-apoptotic programmed cell death In all NSCs
GO:0043071 Positive regulation of non-apoptotic programmed cell death In all NSCs
GO:0045736 Negative regulation of cyclin-dependent protein kinase activity In all NSCs
GO:0009411 Response to UV
GO:0007050 Cell cycle arrest
CpG-rich SP GO:0000070 Mitotic sister chromatid segregation In all ESCs
GO:0000278 Mitotic cell cycle
GO:0007067 Mitosis
GO:0000279 M-phase
CpG-poor SP GO:0006954 Inflammatory response
GO:0048305 Immunoglobulin secretion
GO:0042773 ATP synthesis coupled electron transport
GO:0006122 Mitochondrial electron transport, ubiquinol to cytochrome c
doi:10.1371/journal.pone.0002712.t013
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percentage value for each promoter type contributing to the total.
Found at: doi:10.1371/journal.pone.0002712.s001 (0.72 MB EPS)
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